vidarabine has been researched along with Experimental Hepatoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akagi, K; Sogawa, M; Tanaka, Y | 1 |
| Blum, HE; Geissler, M; Krohne, TU; Mohr, L; Roberts, B; Shankara, S; Wands, JR; Yoon, SK | 1 |
2 other study(ies) available for vidarabine and Experimental Hepatoma
| Article | Year |
|---|---|
[Enhancement of anti-cancer effect by potential lethal damage repair(PLDR)-inhibitors].
Topics: Animals; Cell Line; Cell Survival; Cyclophosphamide; Doxorubicin; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Neoplasms, Experimental; Radiation-Sensitizing Agents; Sarcoma, Experimental; Vidarabine | 1983 |
Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the Escherichia coli purine nucleoside phosphorylase gene.
Topics: Adenoviridae; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Combined Modality Therapy; Escherichia coli; Ganciclovir; Gene Transfer Techniques; Genetic Therapy; Genetic Vectors; Green Fluorescent Proteins; Humans; Liver Neoplasms, Experimental; Luminescent Proteins; Mice; Mice, Nude; Orotate Phosphoribosyltransferase; RNA, Messenger; Thymidine Kinase; Tumor Cells, Cultured; Vidarabine | 2000 |